Skip to main content

Digest

The Weekly Signal

Published August 2, 2026

Executive Summary

This week's digest highlights: Preliminary evidence; confirm full-text methods and endpoints before changing practice. Preliminary evidence; confirm full-text methods and endpoints before changing practice. Preliminary evidence; confirm full-text methods and endpoints before changing practice...

Owen briefs you on what matters in this week's digest.

Think chief-resident chalk talk: what matters, what changes practice, and where to spend your reading time.

Spine

Preliminary evidence; confirm full-text methods and endpoints before changing practice.

High evidence

Why it matters

Policy and payment trends can influence procedure selection, access to care, and practice sustainability in spine surgery.

High-yield

Randomized trial, N=202; intention-to-treat analysis in results; adverse events in safety tables.

Basic Science

Preclinical evidence; no immediate practice change pending clinical validation.

Low evidence

Why it matters

Mechanistic work may identify targets that later translate into neurosurgical oncology or neuroregeneration therapies.

High-yield

Basic science (preclinical); mechanistic endpoints in methods; not applicable (preclinical).

Trials to Know

Why it matters

This prospective observational study aims to identify clinical and radiological factors that predict outcomes after endovascular thrombectomy for large vessel occlusion stroke. Findings may help neurosurgeons refine patient selection and prognostication in acute ischemic stroke management.

Triapine + Radiation for Recurrent Glioblastoma and Astrocytoma

Trial • Trials to Know • ClinicalTrials.gov • 2026-08-02

Why it matters

This phase 1 trial evaluates the safety and tolerability of adding Triapine, a radiosensitizer, to re-irradiation for recurrent glioblastoma and astrocytoma. It addresses the limited salvage options for these patients, where repeat radiation is often constrained by normal tissue tolerance. The trial aims to establish a recommended phase 2 dose and preliminary efficacy.

More context

Key details

  • Phase 1, recruiting

SKYWARD: Intravascular Lithotripsy for Calcified Carotid Arteries Prior to Stenting

Trial • Trials to Know • ClinicalTrials.gov • 2026-08-02

Why it matters

Calcified carotid lesions increase the risk of stenting complications and technical failure. This trial evaluates intravascular lithotripsy (IVL) to modify calcium before trans-carotid stenting, potentially improving outcomes for patients with heavily calcified carotid disease. For neurosurgeons performing carotid revascularization, this addresses the unmet need of safely treating calcified plaques.

More context

Key details

  • Phase NA (Investigational Device Exemption study), Recruiting

From the Preprint Wire

Healthy Aging as Information Divergence in the Multiplex Brain

Preprint • From the Preprint Wire • biorxiv • 2026-07-19

Why it matters

This unreviewed preprint introduces a multiplex network framework to quantify how functional brain connectivity progressively decouples from structural connectivity during healthy aging. For neurosurgeons, understanding this normative trajectory could help distinguish age-expected changes from early neurodegenerative or surgical-related network disruptions.

More context

Key details

  • Analyzed structural and functional connectomes from 589 healthy adults (ages 18–88) in the Cam-CAN dataset.
  • Used Jensen-Shannon Divergence and relative entropy within a multiplex network model to quantify SC-FC interdependencies.
  • Subcortical 'switchboard' regions (putamen, pallidum, caudate, thalamus) were epicenters of age-related functional untethering.
  • Limbic core (hippocampus, entorhinal cortex) showed preserved SC-FC coupling, suggesting resilience of memory circuits.
  • The proposed multiplex baseline could aid in early detection of neurodegenerative disease by contrasting normative aging signatures.

Preoperative EEG Delta-Power Signature Predicts DBS Response in Obsessive-Compulsive Disorder

Preprint • From the Preprint Wire • medrxiv • 2026-07-19

Why it matters

For neurosurgeons evaluating DBS candidacy in refractory OCD, this unreviewed preprint suggests a scalable, non-invasive EEG biomarker may identify likely responders and reduce futile surgeries. It also hints at a mechanistic link to excitation-inhibition balance in fronto-temporal circuits. However, as a preprint, findings require validation in larger prospective cohorts.

More context

Key details

  • EEG signature at a right fronto-temporal electrode was robust across eyes-open/closed states and showed high test-retest reliability.
  • Predictive value was specific to active (not sham) stimulation, supporting biological relevance.
  • Correlated with aperiodic EEG exponent and cortical inhibitory-neuron markers, suggesting a link to cortical excitation-inhibition balance.